Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

SpringLeaf Therapeutics Inc.

www.springleaftx.com

Latest From SpringLeaf Therapeutics Inc.

Financings Of The Fortnight: Life Sciences IPO Wave Continuing Apace

Despite warnings of a slowdown in the IPO market for life sciences firms, the past two weeks saw another wave of S-1 filings by biopharmaceutical companies. Scynexis adjusted goals for its planned IPO, while Corium completed its offering; meanwhile, Endocyte landed a huge FOPO and scPharmaceuticals got off the ground with a $16 million Series A round.

Business Strategies

Start-Up Execs On The Move, November 2012

Recent executive-level hires and director appointments at venture capital firms and biopharma and medtech start-ups.

BioPharmaceutical Medical Device

Pharmaceutical/Biotechnology Deal Statistics Quarterly, Q2 2011

Of the $6.3 billion total raised, 32% was from China distributor Shanghai Pharmaceuticals' $1.99 billion IPO - not only Q2's biggest financing, but also the second-largest pharma IPO of all time. Six of the 26 completed mergers were done to gain access to emerging markets, most notably, Takeda's $13.7 billion buy of Nycomed, almost half of the total $27.9 billion spent on pharma acquisitions this quarter. Q2's largest alliance was Vertex's in-licensing of Alios BioPharma's preclinical HCV nucleotide analogues, a deal that could be worth up to $775 million in up fronts and development milestones.
BioPharmaceutical

Recent Financings of Private Companies (06/11)

Start-Up's monthly comprehensive review of emerging life science companies that have received venture funding during the month, including companies in the pharmaceutical, medical device, diagnostic and research instrumentation and reagent sectors.
See All

Company Information

  • Industry
  • Biotechnology
  • Medical Devices
  • Pharmaceuticals
    • Drug Delivery
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • SpringLeaf Therapeutics Inc.
  • Senior Management
  • Pieter Muntendam, MD, Pres. & CEO
    Shobana Albrecht, VP, Corp. Dev.
    Glenn Larsen, PhD, EVP, R&D & CSO
    Rick Gyory, PhD, VP, Prod. Dev.
  • Contact Info
  • SpringLeaf Therapeutics Inc.
    Phone: (617) 358-4927
    8 St. Mary's St.
    Ste. 601
    Boston, MA 02215
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register